Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
Emma Groarke, Associate Research Physician at the National Institutes of Health, shared on LinkedIn:
”Super excited to see our review on VEXAS syndrome now out in The Lancet Group.
Since VEXAS was first discovered at The National Institutes of Health five years ago, we have developed a large multidisciplinary clinical program encompassing National Heart, Lung, and Blood Institute and National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) seeing patients in our combined hematology and rheumatology clinic and developing therapeutic strategies.
While progress has been made, there is much left learn and discover for our patients.
Alice Fike, Peter Grayson, Bhavisha Patel, Kaitlin Quinn, Benjamin Turturice”
Read the full article here.
Article: VEXAS syndrome: a comprehensive review of pathogenesis, clinical spectrum, and therapeutic strategies
Authors: Emma Groarke, Benjamin Turturice, Bhavisha A. Patel, Kaitlin A. Quinn, Alice Fike, Peter C. Grayso
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids